Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunopathologic events at the endplate in myasthenia gravis.

× No keyword cloud information.

138 in total

Review 1. Control of acetylcholine receptors in skeletal muscle.

Authors: D M Fambrough
Journal: Physiol Rev Date: 1979-01 Impact factor: 37.312

2. An assessment of changes in the complement level of myasthenic sera.

Authors: O J Plescia; J M Segovia; A Strampp
Journal: Ann N Y Acad Sci Date: 1966-01-26 Impact factor: 5.691

Review 3. Serum acetylcholine-receptor antibodies in myasthenia gravis.

Authors: R R Almon; S H Appel
Journal: Ann N Y Acad Sci Date: 1976 Impact factor: 5.691

4. Immunochemical tests of acetylcholine receptor subunit models.

Authors: J Lindstrom; M Criado; S Hochschwender; J L Fox; V Sarin
Journal: Nature Date: 1984 Oct 11-17 Impact factor: 49.962

5. Primary structure of alpha-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence.

Authors: M Noda; H Takahashi; T Tanabe; M Toyosato; Y Furutani; T Hirose; M Asai; S Inayama; T Miyata; S Numa
Journal: Nature Date: 1982-10-28 Impact factor: 49.962

6. Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue culture.

Authors: S Bevan; R W Kullberg; S F Heinemann
Journal: Nature Date: 1977-05-19 Impact factor: 49.962

7. Monoclonal anti-acetylcholine-receptor antibodies directed against the cholinergic binding site.

Authors: D Mochly-Rosen; S Fuchs
Journal: Biochemistry Date: 1981-09-29 Impact factor: 3.162

8. Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors.

Authors: C B Weinberg; Z W Hall
Journal: Proc Natl Acad Sci U S A Date: 1979-01 Impact factor: 11.205

9. Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors.

Authors: B W Fulpius; R Miskin; E Reich
Journal: Proc Natl Acad Sci U S A Date: 1980-07 Impact factor: 11.205

10. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.

Authors: A G Engel; J M Lindstrom; E H Lambert; V A Lennon
Journal: Neurology Date: 1977-04 Impact factor: 9.910

6 in total

Review 1. Immunopathogenesis and treatment of myasthenia gravis.

Authors: A I Levinson; B Zweiman; R P Lisak
Journal: J Clin Immunol Date: 1987-05 Impact factor: 8.317

2. Phenotypic characteristics of thymic B lymphocytes in myasthenia gravis.

Authors: B Zweiman; A I Levinson; R P Lisak
Journal: J Clin Immunol Date: 1989-05 Impact factor: 8.317

Review 3. The role of complement in experimental autoimmune myasthenia gravis.

Authors: Linda L Kusner; Henry J Kaminski
Journal: Ann N Y Acad Sci Date: 2012-12 Impact factor: 5.691

4. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.

Authors: M Z Atassi; K H Ruan; K Jinnai; M Oshima; T Ashizawa
Journal: Proc Natl Acad Sci U S A Date: 1992-07-01 Impact factor: 11.205

Review 5. Complement and systemic lupus erythematosus.

Authors: Mark J Walport
Journal: Arthritis Res Date: 2002-05-09

6. Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus.

Authors: Warren Raymond; Gro Eilertsen; Johannes Nossent
Journal: J Immunol Res Date: 2018-12-30 Impact factor: 4.818

6 in total